General Information of Drug (ID: DM89PMC)

Drug Name
VUF-10148 Drug Info
Synonyms
VUF-10148; CHEMBL261551; 1001065-53-7; VUF 10148; 3-Benzyl-2-(4-methylpiperazinyl)-quinoxaline; SCHEMBL602972; MolPort-027-564-855; PQQUQVYOCGJWAX-UHFFFAOYSA-N; KS-00002WX1; ZINC29054164; BDBM50412496; AKOS016340709; MG-0235
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
24759623
TTD Drug ID
DM89PMC

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histamine H1 receptor (H1R) TTTIBOJ HRH1_HUMAN Inhibitor [1]
Histamine H2 receptor (H2R) TTQHJ1K HRH2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Histamine H1 receptor (H1R) DTT HRH1 5.972 5.7 5.816 6.002
Histamine H2 receptor (H2R) DTT HRH2 5.087 5.121 4.661 4.609
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Histamine H1 receptor (H1R) DTT HRH1 6.74E-01 0.13 0.43
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem. 2008 Apr 24;51(8):2457-67.